Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers

Cancer Research

Volumn 63, Issue 15, 2003, Pages 4620-4625

  Palmisano, William A ^a   Crume, Kevin P ^a   Grimes, Marcie J ^a   Winters, Sally A ^a   Toyota, Minoru ^b   Esteller, Manel ^c   Joste, Nancy ^d   Baylin, Stephen B ^e   Belinsky, Steven A ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CD19 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX5ALPHA; TRANSCRIPTION FACTOR PAX5BETA; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CHROMOSOME 9P; CPG ISLAND; DNA METHYLATION; EMBRYO DEVELOPMENT; EXON; GENE CONTROL; GENE EXPRESSION; GENE MAPPING; GENE SILENCING; GENETIC TRANSCRIPTION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; LUNG CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

AZACITIDINE; B-CELL-SPECIFIC ACTIVATOR PROTEIN; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MICROSATELLITE REPEATS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0043136717     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Baylin, S. B., and Herman, J. G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet., 16: 168-174, 2000.
2. Jones, P. A., and Laird, P. W. Cancer epigenetics comes of age. Nat. Genet., 21: 163-167, 1999.
3. Yang, X., Yan, L., and Davidson, N. E. DNA methylation in breast cancer. Endocr. Relat. Cancer, 8: 115-127, 2001.
4. Zochbauer-Muller, S., Fong, K. K., Maitra, A., Lam, S., Geradts, J., Ashfaq, R., Virmani, A. K., Milchgrub, S., Gazdar, A. F., and Minna, J. D. 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res., 61: 3581-3585, 2001.
5. Du, Y., Carling, T., Fang, W., Piao, Z., Sheu, J-C., and Huang, S. Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res., 61: 8094-8099, 2001.
6. Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., Sekido, Y., Latif, F., Milchgrub, S., Toyooka, S., Gazdar, A. F., Lerman, M. I., Zabarovsky, E., White, M., and Minna, J. D. Epigenetic inactivation of RASSFIA in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst., 93: 691-699, 2001.
7. Toyooka, K. O., Toyooka, S., Virmani, A. K., Sathyanarayana, U. G., Euhus, D. M., Gilcrease, M., Minna, J. D., and Gazdar, A. F. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res., 61: 4556-4560, 2001.
8. Gonzalgo, M. L., Liang, G., Spruck, C. H., III, Zingg, J. M., Rideout, W. M., III, and Jones, P. A. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res., 57: 594-599, 1997.
9. Huang, T. H., Laux, D. E., Hamlin, B. C., Tran, P., Tran, H., and Lubahn, D. B. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res., 57: 1030-1034, 1997.
10. Costello, J. F., Fruhwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomaki, P., Lang, J. C., Schuller, D. E., Yu, L., Bloomfield, C. D., Caligiurri, M. A., Yates, A., Nishikawa, R., Su Huang, H., Petrelli, N. J., Zhang, X., O'Dorisio, M. S., Held, W. A., Cavenne, W. K., and Plass, C. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet., 24: 132-138, 2000.
11. Yan, P. S., Chen, C-M., Shi, H., Rahmatpanah, F., Wei, S. H., Caldwell, C. W., and Huang, T. H-M. Dissecting complex epigenetic alterations in breast cancer using CpG island microarrays. Cancer Res., 61: 8375-8380, 2001.
12. Gitan, R. S., Shi, H., Chen, C. M., Yan, P. S., and Huang, T. H. Methylation-specific oligonucleotide microarry: a new potential for high-throughput methylation analysis. Genome Res., 1: 158-164, 2002.
13. Brock, G. J., Huang, T. H., Chen, C. M., and Johnson, K. J. A novel technique for the identification of CpG islands exhibiting altered methylation patterns (ICEAMP). Nucleic Acids Res., 29: E123, 2001.
14. Toyota, M., Ho, C., Ahuja, N., Jair, K. W., Li, Q., Ohe-Toyota, M., Baylin, S. A., and Issa, J. P. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res., 59: 2307-2312, 1999.
15. Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., and Issa, J-P. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA, 96: 8681-8686, 1999.
16. Toyota, M., Ho, C., Ohe-Toyota, M., Baylin, S. A., and Issa, J. Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5′ CpG island in human tumors. Cancer Res., 59: 4535-4541, 1999.
17. Ueki, T., Toyota, M., Skinner, H., Walter, K. M., Yeo, C. J., Issa, J. P., Hruban, R. H., and Goggins, M. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer Res., 61: 8540-8546, 2001.
18. Stapleton, P., Weith, A., Urbanek, P., Kozmik, Z., and Busslinger, M. Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9. Nat. Genet., 3: 292-298, 1993.
19. Busslinger, M., Klix, N., Pfeffer, P., Graninger, P. G., and Kozmik, Z. Deregulation of PAX-5 by translocation of the Eμ enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc. Natl. Acad. Sci. USA., 93: 6129-6134, 1996.
20. Belinsky, S. A., Palmisano, W. A., Gilliland, F. D., Crooks, L. A., Divine, K. K., Winters, S. A., Grimes, M. J., Harms, H. J., Tellez, C. S., Smith, T. M., Moots, P. P., Lechner, J. F., Stidley, C. A., and Crowell, R. E. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res., 62: 2370-2377, 2002.
21. Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., and Belinsky, S. A. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res., 60: 5954-5958, 2000.
22. Gardiner-Garden, M., and Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol., 196: 261-282, 1987.
23. Antequera, F., and Bird, A. CpG Islands. EXS, 64: 169-185, 1993.
24. Brennan, J. A., Mao, L., Hruban, R. H., Boyle, J. O., Eby, Y. J., Kich, W. M., Goodman, S. N., and Sidransky, D. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332: 429-435, 1995.
25. Koch, W. M., Boyle, J. O., Mao, L., Hakim, J., Hruban, R. H., and Sidransky, D. p53 Gene mutations as markers of tumor spread in synchronous oral cancers. Arch. Otolaryngol. Head Neck Surg., 120: 943-947, 1994.
26. Kozmik, Z., Wang, S., Dorfler, P., Adams, B., and Busslinger, M. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell Bio., 12: 2662-2672, 1992.
27. Nutt, S. L., Morrison, A. M., Dorfler, P., Rolink, A., and Busslinger, M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J., 8: 2319-2333, 1998.
28. Smart, E. T., Yokota, Y., and Gross, P. PAX and HOX in neoplasia. Adv. Genet., 33: 255-274, 1995.
29. Schafer, B. W. Emerging roles for PAX transcription factors in cancer biology. Gen. Physiol. Biophys., 17: 211-224, 1998.
30. Danbara, M., Kameyama, K., Higashihara, M., and Takagaki, Y. DNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell lines. Mol. Immunol., 38: 1161-1166, 2002.
31. Ledbetter, J. A., Rabinovitch, P. S., June, C. H., Song, C. W., Clark, E. A., and Uckun, F. M. Antigen-independent regulation of cytoplasmic calcium in B-cells with a 12-kDa B-cell growth factor and anti-CD19. Proc. Natl. Acad. Sci. USA, 85: 1897-1901, 1988.
32. Salem, C. E., Markl, I. D. C., Bender, C. M. Gonzales, F. A., Jones, P. A., and Liang, G. PAX6 methylation and ectopic expression in human tumor cells. Int. J. Cancer, 87: 179-185, 2000.
33. Adams, B., Dorfler, P., Aguzzi, A., Kozmik, Z., Urbanek, P. Maurer-Fogy, I., and Busslinger, M. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev., 6: 1589-1607, 1992.
34. Urbanek, P., Wang, Z. Q., Fetka, I., Wagner, E. F., and Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell, 79: 751-753, 1994.
35. Stuart, E. T., Haffner, R., Oren, M., and Gruss, P. Loss of p53 function through PAX-mediated transcriptional repression. EMBO J., 14: 5638-5645, 1995.
36. Wales, M. M., Biel, M. A., Deiry, W. E., Nelkin, B. D., Issa, J-P., Cavenee, W. K., Kuerbitz, S. J., and Baylin, S. B. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med., 1: 570-577, 1995.
37. Issa, J-P. J., Zehnbauer, B. A., Kaufmann, S. H., Biel, M. A., and Baylin, S. B. HIC1 hypermethylation is a late event in hematopoietic neoplasms. Cancer Res., 57: 1678-1681, 1997.
38. Carter, M. G., Johns, M. A., Zeng, X., Zhou, L., Zink, M. C., Mankowski, J. L., Donovan, D. M., and Baylin, S. B. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum. Mol. Genet., 9: 413-419, 2000.
39. Esteller, M., Sanchez-Cespedes, M., Rosell, R., Sidransky, D., Baylin, S. B., and Herman, J. G. Detection of aberrant promoter hypermethylatlon of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res., 59: 67-70, 1999.
40. Zou, H. Z., Yu, B. M., Wang, Z. W., Sun, J. Y., Cang, H., Gao, F., Li, D. H., Zhao, R., Feng, G. G., and Yi, J. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer Res., 8: 188-191, 2002.
41. Silva, J. M., Garcia, J. M., Dominguez, O., Silva, J., Miralles, C., Cantos, B., Coca, S., Provencio, M., Espana, P., and Bonilla, F. Persistence of tumor DNA in plasma of breast cancer patients after mastectomy. Ann. Surg. Oncol., 9: 71-76, 2002.